Last $27.97 USD
Change Today +0.93 / 3.44%
Volume 493.3K
KPTI On Other Exchanges
As of 8:10 PM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Sharon Shacham Ph.D., MBA

Co-Founder, Co-Chairman of Scientific Advisory Board, President and Chief Scientific Officer, Karyopharm Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Sharon Shacham, Ph.D., MBA Co-Founded Karyopharm Therapeutics, Inc., in 2008 and has been its Chief Scientific Officer and President since October 2010 and since December 2013 Respectively. Dr. Shacham served as the President of Research & Development at Karyopharm Therapeutics, Inc. since December 2012. until December 2013. Dr. Shacham served as President and Chief Executive Officer of Karyopharm Therapeutics, Inc. from October 2010 to January 2011 and its Chief ...

Read Full Background

Corporate Headquarters*

2 Mercer Road
Natick, Massachusetts 01760

United States

Phone: 508-975-4820
Fax: --

Board Members Memberships*

Co-Founder, Co-Chairman of Scientific Advisory Board, President and Chief Scientific Officer


Tel Aviv University
Tel Aviv University
Tel Aviv University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$380,507

Stock Options*

All Other Compensation$14,288
Exercisable Options160,913
Exercisable Options Value$3,676,155
Unexercisable Options663,851
Unexercisable Options Value$9,715,032
Total Value of Options$13,391,187
Total Number of Options824,764

Total Compensation*

Total Annual Cash Compensation$524,137
Total Short Term Compensation$380,507
Other Long Term Compensation$14,288
Total Calculated Compensation$7,296,085
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KPTI:US $27.97 USD +0.93


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KARYOPHARM THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at